Potential changes to the way the PPF's compensation is calculated and paid could have an impact on its 7800 index and some schemes in its assessment period, as Nick Reeve reports.
Here are the top 5 most-read pulmonary fibrosis articles of 2025.
Newspoint on MSN
Should you invest in PPF while using the new income tax regime? Here's what experts say
Public Provident Fund (PPF) has long been one of India’s most reliable long-term investment options, especially for individuals who prefer stable and low-risk returns. For decades, PPF has played a ...
Large numbers of pension scheme members are affected by the historic issue - and an update has been provided to MPs that ...
A significant update from the Department for Work and Pensions (DWP) suggests that over a quarter of a million people could ...
Every December the Pension Protection Fund (PPF) publishes its ‘Purple Book’, also known as the pensions universe risk ...
More than a quarter of a million people in pension protection schemes could soon receive higher payments after the government ...
Pharmaceutical Technology on MSN
Boehringer’s Jascayd gains China’s NMPA approval for PPF
China’s NMPA has granted approval for Boehringer Ingelheim’s Jascayd (nerandomilast) to treat progressive pulmonary fibrosis (PPF).
Although lottery wins are subject to taxes, there is still a huge lumpsum amount that you take home. It is always wise to use ...
Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | ...
With RBI cutting the repo rate by 125 bps in 2025, bank FD rates have fallen across tenures. While FDs still suit low-tax ...
Newspoint on MSN
SIP vs PPF: Which option builds a bigger corpus in 15 years and which investment is better for you?
SWhen it comes to long-term wealth creation in India, SIP (Systematic Investment Plan) and PPF (Public Provident Fund) are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results